Can a coping workshop ease hopelessness in ovarian cancer?

NCT ID NCT06666218

Terminated Symptom relief Sponsor: Fred Hutchinson Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jul 23, 2026 · Updated 3 times

Summary

This study tests a workshop called HOPE designed to reduce feelings of hopelessness and helplessness in patients with recurrent ovarian cancer. Sixty participants will either attend the workshop or receive usual care. Researchers will measure whether the workshop is feasible, acceptable, and actually improves emotional well-being.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral intervention (HOPE workshop)
What this could lead to: If it works, this could provide a simple, effective way to improve emotional well-being and quality of life for people with recurrent ovarian cancer.
What could go wrong: This is a small, early feasibility study (60 participants) that is currently suspended. It focuses on mental health, not survival, and may not show a clear benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT OVARIAN CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ovarian cancer ovarian carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

RECURRENT OVARIAN CARCINOMA

Contacts and locations

Locations

Fred Hutch/University of Washington Cancer Consortium

Seattle, Washington, 98109, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.